Frank Griscelli holds a Doctor of Pharmacy degree and a Doctor of Science degree. He is a Professor of Biotherapy at ParisCité University with 23 years of research experience in medical oncology and gene therapy. Since 1997, he has served as the chairman of the virology department at Gustave-Roussy Cancer Institute and was involved in overseeing gene therapy clinical trials in collaboration with various industrial promoters such as Transgene, Aventis, and Cobra Therapeutics. Furthermore, he played a pivotal role in establishing and advancing an insurance and quality control laboratory within the American subsidiary of Rhône Mérieux (Athens, GA, USA), specializing in the field of vaccines. Frank Griscelli is the principal investigator within the Inserm research Unit U1310 in the field of cancer immunotherapies based on pluripotent stem cells.
With his major international expertise in biotherapy field encompassing cell and gene therapies, he makes key contributions to the company in preclinical studies, drug formulation, quality control and qualification of therapeutic products and ATMPs
